Vincerx Pharma (VINC) Short Interest Ratio & Short Volume $0.05 0.00 (0.00%) As of 09:50 AM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vincerx Pharma Short Interest DataVincerx Pharma (VINC) has a short interest of 1,000 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 602,655 shares to cover all short positions.Current Short Interest1,000 sharesPrevious Short Interest1,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$43.00Short Interest Ratio0.0 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares5,234,000 sharesPercentage of Shares Shorted0.02%Today's Trading Volume6,789 sharesAverage Trading Volume602,655 sharesToday's Volume Vs. Average1% Short Selling Vincerx Pharma? Sign up to receive the latest short interest report for Vincerx Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVINC Short Interest Over TimeVINC Days to Cover Over TimeVINC Percentage of Float Shorted Over Time Vincerx Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20251,000 shares $43.00 No ChangeN/A0 $0.04 6/30/20251,000 shares $44.00 No Change0.1%0 $0.04 6/15/20251,000 shares $55.00 No Change0.1%0 $0.06 5/31/20251,000 shares $48.50 -50.0%0.1%0 $0.05 5/15/20252,000 shares $100.00 No ChangeN/A0 $0.05 4/30/20252,000 shares $105.00 -98.5%N/A0 $0.05 4/15/2025133,300 shares $36.66 thousand -2.8%3.0%0.1 $0.28 3/31/2025137,200 shares $72.63 thousand +99.4%3.1%0.1 $0.53 3/15/202568,800 shares $56.61 thousand -64.2%3.6%0.1 $0.82 2/28/2025191,900 shares $209.17 thousand +76.9%10.0%0.2 $1.09 Get the Latest News and Ratings for VINC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vincerx Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/2025108,500 shares $141.05 thousand -59.7%5.7%0.2 $1.30 1/31/2025269,200 shares $425.34 thousand +383.3%14.6%0.4 $1.58 1/15/202555,700 shares $170.11 thousand -98.8%N/A0 $3.05 12/31/20244,710,000 shares $1.24 million +1,022.5%N/A0.7 $0.26 12/15/2024419,600 shares $80.14 thousand -42.9%N/A0.6 $0.19 11/30/2024735,400 shares $209.59 thousand +22.6%N/A1.2 $0.29 11/15/2024600,000 shares $177 thousand -26.3%N/A1.1 $0.30 10/31/2024813,800 shares $284.02 thousand -2.8%N/A1.6 $0.35 10/15/2024837,300 shares $318.09 thousand +189.4%N/A1.8 $0.38 9/30/2024289,300 shares $207.14 thousand -28.2%N/A0.7 $0.72 9/15/2024403,000 shares $283.83 thousand +1.4%N/A2.2 $0.70 8/31/2024397,500 shares $325.95 thousand -1.7%N/A2.1 $0.82 8/15/2024404,200 shares $242.12 thousand +7.0%N/A2.1 $0.60 7/31/2024377,900 shares $240.87 thousand -6.2%N/A2 $0.64 7/15/2024403,000 shares $281.41 thousand -31.7%N/A1.5 $0.70 6/30/2024590,000 shares $477.90 thousand +36.2%N/A0.9 $0.81 6/15/2024433,200 shares $294.32 thousand -29.3%N/A0.6 $0.68 5/31/2024612,500 shares $386.49 thousand +7.9%N/A0.8 $0.63 5/15/2024567,500 shares $424.43 thousand -44.9%N/A0.6 $0.75 4/30/20241,030,000 shares $851.81 thousand -14.2%6.0%0.9 $0.83 4/15/20241,200,000 shares $1.04 million +50.0%8.9%1.1 $0.87 3/31/2024799,900 shares $4.05 million -7.4%5.9%0.6 $5.06 3/15/2024863,700 shares $4.82 million +95.2%6.4%0.8 $5.58 2/29/2024442,400 shares $1.66 million +83.3%3.3%0.5 $3.75 2/15/2024241,400 shares $415.21 thousand -29.9%1.8%0.3 $1.72 1/31/2024344,200 shares $450.90 thousand -32.8%2.6%0.7 $1.31 1/15/2024512,500 shares $702.13 thousand +375.9%3.8%1.1 $1.37 12/31/2023107,700 shares $127.09 thousand -12.6%0.8%0.2 $1.18 12/15/2023123,200 shares $77.74 thousand -20.1%0.9%1.8 $0.63 11/30/2023154,200 shares $100.23 thousand +19.8%1.2%3 $0.65Is Elon's empire crumbling? (Ad)The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd. Click here to see the Tesla shock that could blindside everyone. 11/15/2023128,700 shares $99.87 thousand -1.3%1.0%2.4 $0.78 10/31/2023130,400 shares $120.57 thousand -10.6%1.0%1.6 $0.92 10/15/2023145,800 shares $141.43 thousand -13.7%1.1%1.2 $0.97 9/30/2023168,900 shares $170.59 thousand -3.7%1.3%1.4 $1.01 9/15/2023175,400 shares $154.35 thousand -11.8%1.3%1.3 $0.88 8/31/2023198,900 shares $131.27 thousand +87.8%1.5%1.5 $0.66 8/15/2023105,900 shares $91.07 thousand -18.5%0.8%0.8 $0.86 7/31/2023129,900 shares $140.29 thousand +8.3%1.0%1.2 $1.08 7/15/2023120,000 shares $150 thousand -76.7%0.9%1.3 $1.25 6/30/2023514,100 shares $668.33 thousand -18.6%4.0%5.8 $1.30 6/15/2023631,300 shares $965.89 thousand +5.4%4.9%8.1 $1.53 5/31/2023599,200 shares $1.11 million -3.1%4.6%8.5 $1.85 5/15/2023618,300 shares $989.28 thousand +1.9%4.4%10.3 $1.60 4/30/2023607,000 shares $795.17 thousand +3.7%4.3%10.5 $1.31 4/15/2023585,200 shares $575.13 thousand +0.7%4.1%10 $0.98 3/31/2023581,100 shares $604.34 thousand +0.6%4.1%10.1 $1.04 3/15/2023577,700 shares $549.39 thousand -0.4%3.5%7.9 $0.95 2/28/2023580,000 shares $672.80 thousand +0.8%3.6%3 $1.16 2/15/2023575,500 shares $673.34 thousand -1.2%3.6%2.8 $1.17 1/31/2023582,300 shares $879.27 thousand -1.6%3.6%2.5 $1.51 1/15/2023591,900 shares $627.41 thousand -12.8%3.6%2.6 $1.06 12/30/2022678,700 shares $692.27 thousand -31.4%4.2%2.8 $1.02 12/15/2022989,200 shares $797.49 thousand +59.4%6.1%4.1 $0.81 11/30/2022620,500 shares $434.35 thousand -6.5%3.8%5.1 $0.70 11/15/2022663,900 shares $542.27 thousand +0.6%4.1%6 $0.82 10/31/2022660,100 shares $706.31 thousand +6.2%4.0%6.2 $1.07 10/15/2022621,700 shares $714.96 thousand -60.4%3.8%6.1 $1.15 9/30/20221,570,000 shares $2.17 million +2.6%9.6%18 $1.38 9/15/20221,530,000 shares $2.20 million No Change9.3%10.6 $1.44 8/31/20221,530,000 shares $2.33 million -3.2%9.4%8.3 $1.52 8/15/20221,580,000 shares $2.58 million +1.9%9.7%8.3 $1.63 7/31/20221,550,000 shares $2.17 million +0.7%9.5%9 $1.40 7/15/20221,540,000 shares $2.25 million -4.4%9.5%8.9 $1.46 6/30/20221,610,000 shares $2.13 million -10.6%11.0%9.4 $1.32 6/15/20221,800,000 shares $2.65 million +1.1%12.2%11.1 $1.47 5/31/20221,780,000 shares $2.90 million +0.6%12.1%20.3 $1.63 5/15/20221,770,000 shares $3.81 million +0.6%N/A21.3 $2.15 4/30/20221,760,000 shares $4.54 million +2.9%N/A20.8 $2.58 4/15/20221,710,000 shares $4.94 million +7.6%N/A16.1 $2.89 3/31/20221,590,000 shares $6.36 million +13.6%N/A12.7 $4.00 3/15/20221,400,000 shares $5.71 million +6.9%N/A11.5 $4.08 2/28/20221,310,000 shares $6.64 million +1.6%N/A10.4 $5.07 2/15/20221,290,000 shares $8.48 million +13.2%8.8%10.3 $6.57 1/31/20221,140,000 shares $8.20 million +24.6%8.0%9.4 $7.19 1/15/2022915,000 shares $7.32 million +10.1%6.2%9.8 $8.00 12/31/2021831,100 shares $8.47 million +13.1%5.7%11.4 $10.19 12/15/2021734,800 shares $7.62 million +0.7%5.0%9.4 $10.37 11/30/2021729,700 shares $7.65 million -6.6%5.0%7.7 $10.49 11/15/2021781,300 shares $9.77 million +1.9%5.3%7.1 $12.50 10/29/2021766,600 shares $10.71 million -3.4%5.7%6.3 $13.97Is Elon's empire crumbling? (Ad)The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd. Click here to see the Tesla shock that could blindside everyone. 10/15/2021793,500 shares $11.78 million -36.0%7.1%5.9 $14.85 9/30/20211,240,000 shares $20.05 million +12.7%11.1%8.7 $16.17 9/15/20211,100,000 shares $17.40 million -5.2%9.8%6.4 $15.82 8/31/20211,160,000 shares $18.19 million +63.9%10.3%7 $15.68 8/13/2021707,700 shares $9.17 million -2.6%6.3%4.6 $12.96 7/30/2021726,200 shares $9.62 million -3.0%6.5%4.8 $13.25 7/15/2021748,700 shares $10.80 million -1.7%6.7%5.3 $14.42 6/30/2021761,900 shares $9.90 million +65.5%6.8%5.6 $12.99 6/15/2021460,500 shares $5.73 million -6.2%4.1%4.7 $12.44 5/28/2021490,700 shares $6.81 million +2.9%3.0%5.1 $13.88 5/14/2021477,000 shares $7.79 million -12.1%3.0%4.8 $16.34 4/30/2021542,800 shares $8.96 million -6.5%3.3%5.3 $16.50 4/15/2021580,500 shares $11.06 million -6.7%4.5%6.1 $19.05 3/31/2021622,000 shares $12.02 million +13.0%4.8%6.3 $19.33 3/15/2021550,500 shares $12.37 million +17.5%4.2%5.6 $22.47 2/26/2021468,700 shares $8.86 million -16.4%3.6%6.5 $18.90 2/12/2021560,400 shares $9.52 million +66.3%4.3%10.2 $16.98 1/29/2021337,000 shares $6.26 million +317.6%2.7%8.8 $18.57 1/15/202180,700 shares $1.63 million No Change0.7%2.4 $20.20 VINC Short Interest - Frequently Asked Questions What is Vincerx Pharma's current short interest? Short interest is the volume of Vincerx Pharma shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 1,000 shares of VINC short. Learn More on Vincerx Pharma's current short interest. How does Vincerx Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vincerx Pharma: Biophytis S.A. (0.34%), Orgenesis Inc. (0.17%), Hepion Pharmaceuticals, Inc. (0.14%), Viracta Therapeutics, Inc. (0.04%), NuCana PLC Sponsored ADR (478.95%), Trevena, Inc. (0.33%), Bon Natural Life Limited (61.71%), Smart for Life, Inc. (0.01%), Navidea Biopharmaceuticals, Inc. (0.00%), Syros Pharmaceuticals, Inc. (0.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Vincerx Pharma stock? Short selling VINC is an investing strategy that aims to generate trading profit from Vincerx Pharma as its price is falling. VINC shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vincerx Pharma? A short squeeze for Vincerx Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VINC, which in turn drives the price of the stock up even further. How often is Vincerx Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VINC, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Biophytis Short Squeeze Orgenesis Short Squeeze Hepion Pharmaceuticals Short Squeeze Viracta Therapeutics Short Squeeze NuCana Short Squeeze Trevena Short Squeeze Bon Natural Life Short Squeeze Smart for Life Short Squeeze Navidea Biopharmaceuticals Short Squeeze Syros Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VINC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vincerx Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vincerx Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
